DAVID MASSEY: Open Payments
NPI 1922094903 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 29 payments from 7 companies in 2025. Trend: 2023 $493 · 2024 $511 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $129 |
| Collegium Pharmaceutical, Inc. | 5 | $85 |
| Lundbeck LLC | 5 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| ABBVIE INC. | 4 | $63 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: CAPLYTA, Jornay PM, REXULTI, TRINTELLIX, VRAYLAR, Auvelity, FANAPT.
Industry payments across MA — which companies pay providers there.
